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ABSTRACT 
Background – A substantial minority of adolescents suffer from depression and it is 
associated with increased risk of suicide, social and educational impairment, and mental 
health problems in adulthood. A recently conducted randomised controlled trial in England 
evaluated the effectiveness of a  manualised universally delivered age-appropriate CBT 
programme in school classrooms.  The cost-effectiveness of the programme for preventing 
low mood and depression for all participants  from a health and social care sector 
perspective needs to be determined .  
Methods - A trial-based cost-effectiveness analysis based on a cluster randomised 
controlled trial comparing classroom-based CBT to usual school provision of Personal Social 
and Health Education. Per student cost of intervention was estimated from programme 
records.  The study was undertaken in eight mixed sex UK secondary schools, and included 
3,357 school children aged 12 to 16 years (in the two trial arms evaluated in the cost-
effectiveness analysis). The main outcome measures were individual self-reported data on 
care costs, Quality Adjusted Life-Years (QALYs, based on the EQ-5D health-related quality 
of life instrument) and symptoms of depression (Short Mood and Feelings Questionnaire) at 
baseline, 6 and 12 months. 
Results – Although there was lower quality-adjusted life-years over 12 months (-0.05 
QALYs per person, 95% confidence interval -0.09 to -0.005, p = 0.03) with CBT, this is a 
‘clinically’ negligible difference which was not found in the complete case analyses. There 
was little evidence of any between-arm differences in SMFQ scores (0.19, 95% CI -0.57 to 
0.95, p = 0.62), or costs (£142, 95% CI -£132 to £415, p = 0.31) per person for CBT versus 
usual school provision.  
Conclusions: Our analysis suggests that the universal provision of classroom-based CBT is 
unlikely to be either more effective or less costly than usual school provision. 
trial registration - ISRCTN 19083628 
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INTRODUCTION   
Prevalence rates for depression in adolescents suggest that up to 5% may be affected and 
that it is associated with increased risk of suicide, social and educational impairment and 
mental health problems in adulthood (Thapar, Collishaw, Pine, & Thapar, 2012). Whilst 
effective psychological and pharmacological interventions are available, a sizeable 
proportion of adolescents do not respond to these approaches with relapse rates being high 
(Dunn & Goodyer, 2006; Goodyer et al., 2007; March et al., 2004). The need to reduce 
depression at a population level in adolescents has encouraged interest in prevention 
programmes. A Cochrane review concluded that there was evidence that both universal 
(provided for all) and targeted (upon those at risk of depression) programmes may prevent 
depression compared with no intervention (Merry et al., 2011). However, effect sizes are 
typically small, so before the widespread implementation of depression prevention 
programmes can be supported, effectiveness and cost-effectiveness need to be assessed 
under ‘real life’ conditions using appropriate comparisons/control groups. 
 
This paper presents the cost-effectiveness analysis from an NHS and social care 
perspective, of a randomised controlled trial (RCT) of a classroom-based Cognitive 
Behaviour Therapy (CBT) programme, the Resourceful Adolescent Programme (RAP) 
(Shochet & Ham, 2004). The intervention was universally delivered to young adolescents 
(aged 12-16 years) in eight UK secondary schools between 2009 and 2010.  Further details 
of the intervention, the design and conduct of the trial, and the effectiveness results for the 
high-risk adolescents  are published elsewhere (Stallard et al., 2010; Stallard & Buck ., 2013; 
Stallard et al., 2012).  The trial’s effectiveness results showed similar outcomes for high-risk 
adolescents in all three trial arms (see Box 1, below)(Stallard et al., 2012). However this was 
a universally provided programme and it is therefore important to investigate the 
effectiveness of the intervention for all trial participants and to explore data on treatment 
utilization and quality of life.  The aim of this paper is therefore to report the joint analysis of 
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costs and health-related outcomes for all trial participants, taking into account between-arm 
differences in selected co-variates, and possible correlation between costs and outcomes.  
We show results based on changes in our primary mental health outcome e (cost-
effectiveness analysis) and changes in quality-adjusted life-years (often called a ‘cost-utility 
analysis').  We also present the first estimation of the per student cost of such programmes, 
and a detailed breakdown of the health-related service use costs in a large school-based 
sample of 12-16 year olds.. 
    
METHODS 
Cost-effectiveness analysis simultaneously compares the costs and effectiveness of at least 
two alternatives, for example to estimate the additional costs associated with any additional 
benefits gained by a new intervention.  This cost-effectiveness analysis was based on a 
three-arm parallel cluster randomised controlled trial, but in the analysis presented here we 
omit the attention control comparator (because inclusion of this ‘enhanced PSHE’ (Personal 
Social and Health Education) trial arm was primarily to provide evidence relating to 
mechanisms of effectiveness).  Randomisation was at the level of year group balanced on 
school, number of students, number of classes and frequency and timetabling of PSHE 
lessons, with individual participants as the unit of analysis (Stallard et al., 2010).  Eligible 
schools were non-denominational mixed-sex secondary schools in five Local Education 
Authorities, incorporating urban and rural/semi-rural sites in the East Midlands and South 
West of England.  All adolescents in Years 8-11 (aged 12-16 years) in participating schools 
were eligible, unless they were not attending school (e.g., long term sickness, or excluded 
from school) or did not participate in PSHE lessons for religious or other reasons.  
Interventions were delivered in the academic year September 2009 to July 2010 during 
PSHE lessons and  are described in Box 1.   
Box 1. Description of the intervention and comparators in the trial 
Classroom-based CBT (The Resourceful Adolescent Programme)  
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The Resourceful Adolescent Programme (RAP) is a universal depression prevention programme that 
has been shown to be effective in Australia and New Zealand (Merry, McDowell, Wild, Bir, & Cunliffe, 
2004; Shochet & Ham, 2004). The programme was developed to be delivered in schools and 
provided to whole classes of students. The feasibility and viability of delivering RAP in UK schools has 
been established (Stallard & Buck 2013).  
RAP is based upon the principles of cognitive behaviour therapy (CBT) and develops skills reported to 
protect against the development of depression such as emotion-regulation capacities, coping 
mechanisms and thinking styles.  RAP consists of nine modules and two booster sessions, each 
lasting approximately 50-60 minutes. The modules can be flexibly delivered in order to fit within the 
school timetable. The sessions  were led by two trained facilitators working alongside the class 
teacher. All facilitators had at least an undergraduate university degree in a relevant discipline, 
appropriate professional backgrounds or experience of working with children or young people. 
Separate initial training and on-going supervision were provided for the facilitators in the classroom-
based CBT and attention control conditions in order to avoid contamination. (NB. Treatment fidelity 
was assessed by independent observation of a pragmatically stratified 5% sample of classroom-
based CBT sessions.) 
Usual School Provision  
Young people participated in the usual PSHE sessions provided by the school. The sessions were 
provided solely by the teacher and did not involve any external input from the research team. 
Enhanced PSHE (Attention Control)  
Not assessed within the cost-effectiveness analysis – see effectiveness results paper for the high risk 
adolescents and for a fuller description of this condition (Stallard et al., 2012). 
 
 
The analysis of costs and cost-effectiveness was conducted from the perspective of their 
impact on health service (National Health Service (NHS) in England) and social care 
budgets, using prices from the year 2010. It was carried out according to current best 
practice methods for conducting economic evaluation alongside trials (Glick, 2007; Ramsay 
et al., 2005), and alongside cluster randomised controlled trials (Diaz-Ordaz, Kenward, & 
Grieve, 2012; Gomes, 2011). 
 
Outcome measures 
Outcomes were collected during class time by self-completed questionnaire administered to 
students by researchers at baseline, 6 months and 12 months follow up (Stallard et al., 
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2010). The outcomes used in the cost-effectiveness analysis were: Quality Adjusted Life-
Years (QALYs) from baseline to 12 months, using data from the EQ-5D questionnaire at 
three time-points, and; symptoms of low mood as determined by the Short Mood and 
Feelings Questionnaire (SMFQ) ( Angold et al., 1995). 
The EQ-5D is a simple and well-established 5-question health-related quality of life 
instrument which covers health impacts on physical mobility, self-care ability, usual activities, 
pain/discomfort and anxiety/depression (www.euroqol.org).  Every pattern of possible EQ-5D 
responses can be attributed a preference weight between one (= ‘full health’) and zero (= as 
bad as being dead), and it is these weights which are used to convert life-years into quality-
adjusted life-years (or ‘QALYs’). The preference weights for the EQ-5D index scores were 
from a representative sample survey of the UK general population in 1993 (Kind, Hardman, 
& Macran, 1999). 
 
The SMFQ assess symptoms of low mood and is a 13-item scale derived from the 33-item 
Mood and Feelings questionnaire ( Angold et al., 1995, Costello & Angold 1988).  Each item 
consists of a simple statement (e.g. ‘I didn't enjoy anything at all’), which is rated as being 
‘true’ (scores 2),‘sometimes true’ (scores 1) or ‘not true’ (scores 0) in relation to the past two 
weeks). The SMFQ correlates well with other measures of depression and has good test–
retest reliability, and higher scores are associated with fulfilling diagnostic criteria for clinical 
depression (Angold et al., 1995,). 
 
This paper examines the cost-effectiveness of  a universally delivered school based  
intervention and so data from all all students in participating classes were included. 
Service use data 
Data on the use of a wide range of health and social care services were collected from the 
pupils using an adapted and age-appropriate self-completed version of the Client Services 
Receipt Inventory (CSRI) (Beecham & Knapp, 2001). This self-completed version had been 
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used and amended in the pilot study (Stallard & Buck, 2013). This cost of service use data 
from all three time-points (baseline, 6 and 12 months) were included in the cost-
effectiveness analysis. Details of the services and resoucres assessed are summarised in 
Table 1. 
  
*** TABLE 1 ABOUT HERE *** 
 
The unit costs applied to the different types of health service use, or for visits to see different 
types of care professionals about anxiety of depression are provided in Table B (in the online 
Appendix).  The two main sources for the unit costs were the Department of Health’s 
National Schedule of Reference Costs (for Primary Care Trusts and NHS Trusts combined) 
and the Personal Social Services Research Unit’s Unit Costs of Health and Social Care 
(hourly costs of patient or client contact for various types of health or social care 
professional)(Curtis, 2011; Department of Health, 2011). 
The reason given for each reported inpatient stay was assessed as being either elective or non-
elective and relevant unit costs applied. For the very small minority (<1%) of participants who 
reported taking medication for anxiety or depression, the information provided on medication 
names and how long they had been taken was too unreliable to use as a basis for estimating 
these costs. For example, the type of medicine taken was simply recorded by some as ‘don’t 
know’ or ‘can’t remember’, or stated ‘paracetamol’ or other over-the-counter medications or herbal 
remedies, which would have no cost implications for the NHS. The self-reported medication data 
were therefore excluded from further analysis.  
Costing the interventions 
The resource use involved in providing the classroom-based CBT programme was costed 
using detailed project records of staff time and other expenditure. This included the paid time 
of facilitators delivering the programme, cost of their training and ongoing supervision and 
management, travel costs, printing costs of course booklets, and an apportionment of the 
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cost of recruiting schools.  The calculated intervention costs excluded the costs of 
developing or adapting the new materials (these were treated as ‘sunk costs’ – it is assumed 
they would not be incurred again) or the estimated proportions of people’s time which are 
due to the research/trial context of programme delivery.  The costs did, however, include a 
share of the initial training costs of the facilitators (time of trainers and facilitators, room hire 
and subsistence).  Usual provision of PSHE lessons involved no intervention costs. 
All costs were calculated as either the amount of resource used multiplied by a unit cost, or 
as the total amount incurred over the trial period divided by the number of pupils in 
participating classes, number of sessions delivered, or number of schools, depending on the 
level at which the cost was incurred. Table A (online supporting materials) shows the key 
data and costs that were used to calculate the mean intervention cost per student.    
Statistical analysis of the cost-effectiveness data 
The cleaning and correction of resource use and EQ-5D data, and the calculation of service 
use costs were conducted in PASW Statistics v18 (www.SPSS.com). The models for 
analysing incremental cost-effectiveness were fitted using Stata 12 software 
(www.stata.com).  Given the relatively short timeframe of the trial and follow-up, neither 
costs nor outcomes were discounted to present values (i.e. preferences over the timing of 
future costs and outcomes would have a negligible impact on the results). 
Two cost-effectiveness analyses were conducted, one using the SMFQ score (the primary 
outcome measure for the effectiveness trial) and another using quality-adjusted life-years 
(QALYs) based on responses to the EQ-5D questionnaire. The derivation of the per person 
QALYs from baseline to 12 months involved: calculating the social preference weight (or 
utility) for all those who completed the EQ-5D at each of the three time points; estimating the 
‘area under the curve’ between baseline and 6 months and between 6 months and 12 
months, and summing them. QALYs were therefore calculated only for students who had 
complete EQ-5D data at all three time points.  
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Incremental costs, incremental effects, and where relevant, incremental cost-effectiveness 
ratios (ICERs) were estimated, comparing the classroom-based CBT arm to the Usual 
School Provision arm. The incremental cost per unit decrease in the SMFQ score (since 
lower scores on the SMFQ indicate better outcome) and the incremental cost per unit QALY 
increase were estimated.  Both unadjusted and adjusted analyses were carried out, 
adjusting for Year level for all outcomes and additionally for SMFQ score at baseline when 
analysing the SMFQ outcome.  The remaining factors used to balance the randomisation 
were not adjusted for due to the relatively small number of clusters. 
In the complete case analyses, random effects bivariate linear regression models were fitted 
to model cost and effectiveness (SMFQ or QALY) simultaneously, allowing for correlation 
within randomised clusters and correlation between cost and effectiveness score within 
participants (Goldstein, 2003). These models produced estimates of: the mean difference in 
cost and its standard error; the mean difference in effect and its standard error; and 
(indirectly via the variance-covariance matrix of the regression coefficients) the correlation 
between the mean cost difference and the mean effect difference. 
Note that because the cost of the intervention must be apportioned across all participants in 
a given trial arm, both the SMFQ- and QALY-based cost-effectiveness results are based on 
the whole sample who had valid cost and outcome data i.e. not just those assessed as high 
risk (SMFQ) at baseline, as in the primary effectiveness analysis(Stallard et al. 2012).  
The findings reported here are based on analyses of multiple imputed data, making the 
assumption that the any missing cost or effect data are missing at random. Imputation and 
analysis models that explicitly allow for the clustered design were used (Diaz-Ordaz et al., 
2012).  The following variables were included in the imputation model: cost, SMFQ scores 
and QALY scores at each of baseline, 6 months and 12 months; trial arm status; and the 
variables used to balance the randomisation.  The data were imputed and analysed using 
the software REALCOM Impute package (www.bristol.ac.uk/cmm/software/realcom/) in 
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conjunction with Stata software, version 12 (www.stata.com).    The imputed datasets were 
analysed in Stata using the mi commands.  Findings from the complete case analyses of 
non-imputed data indicated essentially the same interpretation as the reported analyses 
based on imputed data (see Appendix 1). 
RESULTS 
Of the 5,503 eligible students, 5,030 (91%) consented to participate in the trial, of whom 
3,357 (1,753 CBT arm and 1,604 control arm) were allocated to the two trial arms analysed 
here.  Of these, 2,237 had valid cost data, 2,767 had valid SMFQ data at 12 months and 
2,087 had valid EQ-5D (QALY) outcome data (i.e., at all three time points).  All participants 
(including those with missing data) were included in the analyses of imputed data. 
The classroom-based CBT intervention costs an estimated £41.96 per student, most of 
which was due to the cost of facilitator time to deliver the sessions (see Table 2). Note that 
the training costs within these per student costs reflect the relatively high ratio of the 
number of facilitators to total number of classes delivered (39 facilitators to deliver 787 
sessions to 79 classes for classroom-based CBT), which might not be as high if the 
classroom-based CBT programme were rolled out on a larger scale and for a longer period 
of time.  Table 3 shows the very similar health and social care service usage and care 
costs for the two trial arms in the six months before, during and after the intervention. 
*** TABLE 2 ABOUT HERE *** 
*** TABLE 3 ABOUT HERE *** 
Table 4 summarises the comparison between the classroom-based CBT and usual 
school provision arms with respect to cost for the 12-month period of the trial, SMFQ 
score at 12 months and QALYs (from 0 to 12 months). Incremental analyses which are 
either unadjusted or adjusted for covariates are shown. Incremental analysis compares 
the gain or loss in effectiveness with the additional costs, or cost savings, with one 
intervention compared with another. The point estimates indicate that CBT is more costly 
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and less effective than usual school provision, with respect to both SMFQ and QALYs, 
but these differences are both very small and uncertain (with the 95% confidence 
intervals spanning zero for both costs and SMFQ differences).  Although the analysis in 
Table 4 shows a small negative mean difference in QALYs (-0.05), which is statistically 
significant in the adjusted analysis (p= 0.03), this is the only finding amongst all the 
adjusted or unadjusted, and imputed dataset or complete case analyses which shows a 
statistically significant result; the magnitude of this difference is also smaller than most 
estimates of the ‘minimally important difference’ for the EQ-5D (Walters & Brazier 2005, 
Le et al 2013).   Thus we conclude that classroom-based CBT is highly unlikely to be 
cost-effective.   
*** TABLE 4 ABOUT HERE *** 
DISCUSSION   
Despite high levels of fidelity and adherence, the main trial indicated that a universally 
provided classroom-based CBT depression prevention programmes delivered in schools 
was not effective for adolescents at high-risk of depression  (data reported elsewhere)( 
Stallard et al.,2012).  Taking into account the data on both costs and effects for all trial 
participants from a health and social care perspective, the cost-effectiveness analysis 
reported here has provided little evidence that universal classroom-based CBT is likely to be 
either more effective or associated with lower costs than usual school provision.  
 
While this cost-effectiveness result might seem an obvious implication of the main 
effectiveness results from the trial, this is not always the case, for the following reasons.  
First, unlike RCTs of effectiveness, economic evaluations are primarily about estimation 
rather than hypothesis testing in their analytical approach.  Secondly, the sample sizes of 
RCTs are typically powered on the basis of expected effects on the primary clinical outcome, 
and not on expected differences in costs.  Thirdly, because individual level costs and 
effectiveness are often correlated, so too are incremental costs and effects, and the direction 
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and strength of correlation can substantially alter the likelihood that that an intervention may 
be judged as cost-effective – even in the context of a statistically non-significant 
effectiveness result for the primary outcome.  For these reasons health economists 
recommend the conduct of a full cost-effectiveness analysis, as we have presented here, 
even in the context of no statistically significant impact on the primary clinical outcomes 
(Drummond et al 2005). 
 
This cost-effectiveness analysis is based on the first large-scale pragmatic randomised trial 
to compare a universal depression focused classroom-based CBT programme with usual 
school provision on symptoms of low mood/depression in adolescents.  The collection of 
cost data and the cost-effectiveness analyses were carried out according to current best 
practice methods for conducting economic evaluation alongside randomised trials (Diaz-
Ordaz et al., 2012; Glick, 2007; Gomes, 2011; Ramsay et al., 2005).  The statistical methods 
of the cost-effectiveness analysis have accounted for the clustered nature of the data and 
any correlation between costs and effects.  Analysis was based on effectiveness measures 
of established validity and reliability, and the self-report data were relatively complete. It 
incorporated a detailed ‘bottom-up’ costing of classroom-based CBT based on accurate 
records of staffing, resources and other activities involved.  We have also adjusted for or 
omitted those intervention costs ( ‘protocol-driven’ costs) which would, in all likelihood, not 
be incurred outside of a research trial context; and those which would not be incurred with 
the widespread roll-out of such interventions (e.g. adaptation of course materials). 
 
The main study limitations relate to the trial design and conduct include: the CBT programme 
evaluated was developed for use with children aged 12-15 years of age and the inclusion of 
16 year olds could have reduced the effects; the approach of delivering the intervention to all 
children in order to prevent depression in the minority who are at high risk of depression may 
have affected the overall potency of the intervention; and participants were not blinded to 
treatment allocation. There are also some limitations specific to the cost-effectiveness 
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analysis.  The requirement that participants self-report relevant cost and effectiveness data 
(i.e., EQ-5D responses) inevitably results in some missing data.  In accordance with current 
best practice methods, we have imputed missing cost and effect data for the analysis 
presented here; but we also (in Appendix 1) show that results based on analysis of complete 
cases are very similar, and support identical conclusions.  Lastly, without linked data 
collection from health or other support services, it is not possible to assure the validity and 
reliability of the self-report of service use data from children of these ages. Other research, in 
adults, suggests that patient self-report agrees closely with service/provider records for 
hospital use, with recall periods of up to six months, but that for medication and other care 
products patient recall can be quite incomplete (van den Brink, van den hout, Stigglebout, 
van de Velde, & Kievit, 2004).   
  
There are currently very few economic evaluations of similar group-CBT programmes for low 
mood or depression, and only one that is for depression prevention which targets children or 
adolescents (Lynch et al., 2005).  This cost-effectiveness study was of a 15-session group 
CBT intervention for the 13 to 18 year-old children of depressed parents, in a large health 
maintenance organisation in the USA; the incremental cost, incremental cost per 
depression-free day or the incremental cost per QALY were not statistically significantly 
different from usual care (based on 95% confidence intervals).  Overall, it is not possible to 
judge whether our findings are consistent with those of similar studies because of the lack of 
trial-based economic evaluations of group-CBT to prevent depression, or of other 
interventions to prevent low mood and anxiety in children. 
 
We estimated that the per student costs of the CBT programme were approximately £40 per 
student.   With these modest per student programme costs even small mean QALY gains – if 
gained with greater certainty – would be judged as cost-effective by NHS policy makers in 
England.  For example, an 0.005 QALY gain per student for an additional cost of £40 implies 
an incremental cost-effectiveness ratio of only £8,000 per QALY gained; this is well under 
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the usual threshold (£20,000 per QALY) regarded by the National Institute of Health and 
Care Excellence as separating cost-effective from non-cost-effective use of NHS resources.  
The CBT programme costs would be further reduced if the cost of training each facilitator 
was spread across more sessions delivered per facilitator.  Nevertheless, such speculation 
is only useful in the context of more certain differences in effectiveness and impact on quality 
of life than our randomised trial actually found. 
 
In conclusion, we found no evidence to suggest that a universally delivered classroom-based 
CBT programme designed to prevent symptoms of depression in adolescents wascost-
effective over a one year time period. The clear implication for policy makers at this time is 
therefore that such programmes should not be implemented.  Future studies of such 
programmes should always incorporate and report well designed and properly conducted 
cost-effectiveness analysis, in order to compare any detected health gains with the 
opportunity costs and savings of delivering the programme.  
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Key Points 
A substantial minority of adolescents suffer from depression, yet there are few proven 
approaches to preventing low mood and depression in this age group. 
This study evaluated the cost-effectiveness of a universally provided classroom-based group 
CBT intervention, based on a high quality cluster-randomised trial in 8 secondary schools in 
England. 
This study yielded no evidence that the intervention was cost-effective over a one-year time 
period in this school-based sample of 12-16 year olds 
Our findings suggest that classroom-based universal CBT interventions should not be 
routinely implemented, and the effectiveness and cost-effectiveness of similar programmes 
should be rigorously evaluated 
19 
 
 
REFERENCES 
Angold, A., Costello, E., Messer, S., Pickles, A., Winder, F., & Silver, D. (1995). Development of a short 
questionnaire for use in epidemiological studies of depression in children and adolescents. . 
International Journal of Methods in Psychiatric Research, 5, 237-249.  
Beecham, J., & Knapp, M. (2001). Costing psychiatric interventions. In G. Thorncroft (Ed.), Measuring 
Mental Health Needs. London: Gaskell. 
Costello E, Angold A. (1988) Scales to assess child and adolescent depression: checklist, screens and 
nets. Journal of the American Academy of Child & Adolescent Psychiatry 27, 726–37. 
Curtis, L. (2011). Unit Costs of Health and Social Care 2010. Canterbury, Kent: Personal Social 
Services Research Unit. 
Department of Health. (2011). NHS reference costs 2009-2010 [for NHS Trust and PCT combined].  
Retrieved 12 January 2012, from Department of Health, England 
http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuid
ance/DH_123459 
Diaz-Ordaz, K., Kenward, M., & Grieve, R. (2012). Handling missing values in cost-effectiveness 
analyses that use data from cluster randomised trials. RSS Journal Series A, EarlView Online.  
Dunn, V., & Goodyer, I. (2006). Longitudinal investigation into childhood- and adolscence-onset 
depression: psychiatric outcome in early adulthood. British Journal of Psychiatry, 188, 216-
222.  
Glick, H. A., Doshi, J.A., Sonnad, S.S., Polsky, D. (2007). Economic Evaluation in Clinical Trials: Oxford 
University Press. 
Goldstein, H. (2003). Multilevel Statistical Models (3rd Edition). London: Arnold. 
Gomes, M., Grieve, R., Nixon, R., Edmunds, W.J. (2011). Statistical Methods for Cost-Effectiveness 
Analyses That Use Data from Cluster Randomized Triels: A Systematic Review and Checklist 
for Critical Appraisal. Medical Decision Making, 12.  
Goodyer, I., Dubicka, B., Wilkinson, P., Kelvin, R., Roberts, C., Byford, S., . . . Harrington, R. (2007). 
Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without 
cognitive behaviour therapy in adolescents with major depression: randomised controlled 
trial. British Medical Journal, 335(7611), 142-146A. doi: 10.1136/bmj.39224.494340.55 
20 
 
Kent L, Vostanis P, Feehan C. (1997) Detection of major and minor depression in children and 
adolescents: evaluation of the mood and feelings questionnaire.  Journal of Child Psychology 
& Psychiatry 38, 565–73. 
Kind, P., Hardman, G., & Macran, S. (1999). UK Population Norms for EQ-5D. Discussion Paper 172  
Retrieved January, 2012, from 
http://www.york.ac.uk/media/che/documents/papers/discussionpapers/CHE%20Discussion
%20Paper%20172.pdf 
Lynch, F. L., Hornbrook, M., Clarke, G., Perrin, N., Polen, M. R., O'Connor, E., & Dickerson, J. (2005). 
Cost-effectiveness of an intervention to prevent depression in at-risk teens. Archives of 
General Psychiatry, 62, 1241-1248.  
March, J., Silva, S., Petrycki, S., Curry, J., Wells, K., Fairbank, J., . . . Treatment Adolescent Depression, 
S. (2004). Treatment for adolescents with depression study (TADS) team . Fluoxetine, 
cognitive-behavioural therapy, and their combination for adolescents with depression; 
Treatment for adolescents with depression study (TADS) randomized controlled trial. JAMA, 
292, 807-820.  
Merry, S., McDowell, H., Wild, C. J., Bir, J., & Cunliffe, R. (2004). A randomized placebo-controlled 
trial of a school-based depression prevention program. Journal of the American Academy of 
Child and Adolescent Psychiatry, 43(5), 538-547.  
Merry, S. N., Hetrick, S. E., Cox, G. R., Brudevold-Iversen, T., Bir, J. J., & McDowell, H. (2011). 
Psychological and educational interventions for preventing depression in children and 
adolescents (Review). Cochrane Database of Systematic Reviews, (12). Retrieved from 
http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD003380.pub3/pdf website:  
doi:10.1002/14651858.CD003380.pub3. 
Le, Q.A., Doctor, J.N., Zoellner, L.A., Feeny,N.C. (2013). Minimally important clinical differences for 
the EQ-5D and QWB-SA in Post-Traumatic Stress Disorder (PTSD): results from a Doubly 
Randomized Preference Trial (DRPT)  Health and Quality of Life Outcomes, 11: 59 
Ramsay, S., Willke, R., Briggs, A., Brown, R., Buxton, M., Chawla, A., . . . Reed, S. (2005). Good 
research practices for cost-effectiveness analysis alongside clinical trials: The ISPOR RCT-CEA 
Task Force Report. . Value in Health, 8(5), 521-520.  
Shochet, I., & Ham, D. (2004). Universal school-based approaches to preventing adolescent 
depression: past findings and future directions of the Resourceful Adolescent Program. 
International Journal of Mental Health Promotion, 6(3), 17-25.  
21 
 
Stallard, P. and Buck, R., 2013. Preventing depression and promoting resilience : Feasibility study of a 
school-based cognitive-behavioural intervention. The British Journal of Psychiatry, 202 
(Supplement 54), s18-s23. 
Stallard, P., Montgomery, A., Araya, R., Anderson, R., Lewis, G., Sayal, K., . . . Taylor, J. (2010). 
Protocol for a randomised controlled trial of a school based cognitive behaviour therapy 
(CBT) intervention to prevent depression in high risk adolescents (PROMISE). Trials, 11(114).  
Stallard, P., Phillips, R., Montgomery, A., Anderson, R., Taylor, J., Araya, R., . . . Sayal, K. ( 2013 ). A 
cluster randomised controlled trial to determine the effectiveness and cost-effectiveness of 
classroom-based Cognitive Behavioural Therapy (CBT) in reducing symptoms of depression 
in high-risk adolescents. Health Technology Assessment. 17 (47). 
Stallard, P., Sayal, K., Phillips, R., Taylor, J., Spears, M., Anderson, R., . . . Montgomery, A. (2012). 
Classroom based cognitive behaviour therapy in reducing symptoms of depression in high 
risk adolescents: pragmatic randomised controlled trial BMJ (Vol. 345, pp. e6058). 
Thapar A, McGuffin P. (1998) Validity of the shortened Mood and Feelings Questionnaire in a 
community sample of children and adolescents: a preliminary research note. Psychiatry 
Research 81, 259–68. 
Thapar, A., Collishaw, S., Pine, D., & Thapar, A. (2012). Depression in adolescence. Lancet, 379, 1056-
1067.  
van den Brink, M., van den hout, W. B., Stigglebout, A. M., van de Velde, C. J. H., & Kievit, J. (2004). 
Cost measurement in economic evaluations of health care: whom to ask? Medical Care, 
42(8), 740-746.  
Walters, S.J., Brazier, J.E. (2005). Comparison of the minimally important difference for two health 
state utility measures: EQ-5D and SF-6D Quality of Life Research, 14(6), 1523-1532. 
 
  
22 
 
Table 1: Details of service and resource use recorded 
Type of service use Details recorded Notes or limits 
Overnight hospital stays Reason, and no. of days in hospital For up to 3 stays 
Accident and Emergency visits No. of visits, reasons for visits Up to 3 reasons 
Hospital outpatient appointments No. of visits, reasons for visits Up to 3 reasons 
Visits to the GP No. of visits, no. of visits for worry anxiety 
or unhappiness 
 
“Seen anyone else for 
psychological problems (such as 
worry, anxiety or unhappiness)” 
No. of times seen (for each of: Nurse at a 
GP practice, School nurse, Counsellor, 
Child Mental Health Service, Child 
psychologist, Social worker, or “Someone 
else, please say who ………”) 
 
Taking medication (for anxiety or 
depression) 
Name of medicine, how long taken Up to 2 medicines 
 
 
 
Table 2: Per student cost (£) of delivering classroom-based CBT  
Type of cost 
classroom-
based CBT 
Cost of training and managing facilitators 9.84 
Cost of facilitator time delivering the 
intervention  29.37  
Intervention booklet (printing) costs per 
child 1.41  
Travel costs of facilitators  1.23  
Allocation of school recruitment costs  0.12  
Cost per child receiving intervention 41.96 
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Table 3. Number of students and cost of using health care over the study period. 
 (a) baseline (i.e. pre-intervention, from -6 to 0 months): 
Type of care use CBT   Usual PSHE    
 
No.   (%) 
Mean 
cost £ (SE) No.  (%) 
Mean 
cost £ (SE) 
Inpatient stays 45 (4.5) 72.09 (16.4) 33 (3.1) 50.48 (14.8) 
A&E attendances 167 (16.6) 26.93 (2.6) 169 (15.8) 25.19 (2.2) 
Outpatient visits 226 (22.5) 46.25 (3.9) 234 (21.9) 37.21 (3.4) 
TOTAL hospital use/costs 328 (32.6) 145.27 (18.8) 335 (31.4) 112.89 (16.6) 
GP (for any reason) 448 (44.5) 28.76 (1.7) 440 (41.2) 25.49 (1.6) 
GP (for psychological problems) 33 (3.3) 1.94 (0.4) 29 (2.7) 1.41 (0.3) 
GP Nurse 26 (2.6) .51 (0.1) 12 (1.1) .17 (0.1) 
School Nurse 30 (3.0) .76 (0.2) 18 (1.7) .97 (0.4) 
Counsellor 14 (1.4) 2.80 (1.0) 7 (0.7) 1.07 (0.5) 
CMHS 6 (0.6) .81 (0.4) 5 (0.5) .81 (0.4) 
Child Psychologist 7 (0.7) 3.06 (1.7) 2 (0.2) 1.14 (1.0) 
Social Worker 4 (0.4) 1.63 (0.9) 6 (0.6) .70 (0.3) 
Other professional 64 (6.4) 9.58 (2.5) 43 (4.0) 4.86 (1.5) 
TOTAL all service use/costs 607 (60.3) 183.61 (19.6) 615 (57.6) 143.24 (17.0) 
(b) from 0 to 6 months: 
Type of care use CBT    Usual PSHE    
 
No. (%) 
Mean 
cost £ (SE) No. (%) 
Mean 
cost £ (SE) 
Inpatient stays 36 (3.6) 43.62 (9.1) 27 (2.5) 52.66 (16.3) 
A&E attendances 158 (15.7) 22.93 (2.1) 144 (13.5) 21.43 (2.2) 
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Outpatient visits 212 (21.1) 47.93 (4.8) 227 (21.3) 39.80 (3.6) 
TOTAL hospital use/costs 309 (30.7) 114.48 (12.5) 311 (29.1) 113.89 (18.0) 
GP (for any reason) 404 (40.2) 26.24 (1.9) 445 (41.7) 25.70 (1.4) 
GP (for psychological problems) 35 (3.5) 1.92 (0.4) 27 (2.5) 1.78 (0.5) 
GP Nurse 21 (2.1) .46 (0.1) 11 (1.0) .25 (0.1) 
School Nurse 15 (1.5) .39 (0.1) 5 (0.5) .24 (0.1) 
Counsellor 17 (1.7) 4.37 (1.5) 10 (0.9) 2.60 (1.2) 
CMHS 5 (0.5) 1.24 (0.8) 4 (0.4) .45 (0.2) 
Child Psychologist 4 (0.4) 2.62 (1.5) 1 (0.1) .08 (0.1) 
Social Worker 4 (0.4) 1.53 (1.1) 3 (0.3) .35 (0.2) 
Other professional 51 (5.1) 11.50 (3.6) 27 (2.5) 4.01 (1.3) 
TOTAL all service use/costs 579 (57.6) 152.22 (13.6) 608 (57.0) 143.60 (18.2) 
(c) from 6 to 12 months: 
Type of care use CBT    Usual PSHE    
 
No. (%) 
Mean 
cost £ (SE) No. (%) 
Mean 
cost £ (SE) 
Inpatient stays 30 (3.0) 59.71 (19.8) 20 (1.9) 21.78 (6.9) 
A&E attendances 145 (14.4) 21.30 (2.2) 126 (11.8) 16.12 (1.7) 
Outpatient visits 179 (17.8) 36.41 (3.5) 198 (18.6) 33.68 (3.1) 
TOTAL hospital use/costs 275 (27.3) 117.42 (21.8) 273 (25.6) 71.58 (8.5) 
GP (for any reason) 368 (36.6) 22.30 (1.5) 427 (40.0) 21.89 (1.1) 
GP (for psychological problems) 36 (3.6) 2.35 (0.5) 17 (1.6) .97 (0.3) 
GP Nurse 28 (2.8) .46 (0.1) 19 (1.8) .40 (0.1) 
School Nurse 14 (1.4) .65 (0.3) 18 (1.7) .43 (0.1) 
Counsellor 21 (2.1) 4.42 (1.2) 14 (1.3) 2.43 (0.8) 
CMHS 10 (1.0) .72 (0.3) 2 (0.2) .22 (0.2) 
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Child Psychologist 2 (0.2) .40 (0.3) 3 (0.3) 1.21 (0.8) 
Social Worker 4 (0.4) .26 (0.1) 4 (0.4) .20 (0.1) 
Other professional 56 (5.6) 8.94 (2.5) 39 (3.7) 4.91 (1.4) 
TOTAL all service use/costs 529 (52.6) 148.66 (22.3) 585 (54.8) 98.38 (8.8) 
Percentages are of all those who adequately completed the service and resource use questionnaire for that period.  
A&E = Accident and Emergency. GP = General Practitioner.  CMHS = Community Mental Health Service. SE = Standard Error of the mean. 
 
 
 
  
27 
 
Table 4: Incremental per student effectiveness and costs of classroom-based CBT versus usual school provision (control) 
Outcome  CBT  Control  unadjusted                  adjusted 
    mean (SD)*    mean (SD)*    mean difference    mean difference  (95% CI) p-value 
          
Cost (in £)  553 (1392)  406 (1240)  167  142  (-132  to  415) 0.31 
SMFQ score  3.9 (5.4)  3.2 (4.5)  0.48  0.19  (-0.57 to  0.95) 0.62 
QALYs   0.90 (0.12)  0.91 (0.12)  -0.06  -0.05  (-0.09  to  -0.005) 0.03 
          
* Mean and standard deviations (SD) calculated based on non-missing participants only; between arm comparisons based on analysis of 
imputed data.
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Table A and B below to be made available as an online Appendix 
Table A Costs and other key data for calculating the per student intervention 
costs  
Type of cost or other resource relevant data 
Classroom-
based- CBT 
Hours of coordinator time to organise staff  150  
Total no. of classes receiving the intervention 79  
Total no. of students in the programme* 2,030 
Mean no. of students per class (all on roll) 25.7 
Total no. of sessions delivered  787  
Mean no. of sessions received per class  9.96  
Total no. of facilitators who delivered sessions 39 
No. of sessions delivered per school visit (for travel costs) 3 
Total salary cost of those providing the intervention £59,621 
Total cost of training facilitators £18,418 
Cost of staff time recruiting each school to the programme £60 
Cost of travel for recruiting each school to the programme £20 
*NB: This differs from the numbers in the trial arms because the intervention costs must be shared amongst all who received the 
intervention, not just those who consented to involvement in the study and also completed the assessment booklets. 
 
 
 
 
 
 
 
 
Table B. Unit costs applied for each type of service use (in 2010 £) 
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Q No. Resource type and unit Unit cost (£) Source 
Q6-11 Inpatient stays – elective 781 per day NSRC2009-10 See note c 
Q6-11 Inpatient stays – non-elective short-
stay (1 day/night) 
520 per day NSRC2009-10 See note c 
Q6-11 Inpatient stays – non-elective long-
stay (>1 day/night) 
386 per day NSRC2009-10 See note c 
 
Q13-16 A & E attendances 103 NSRC2009-10 A&E Services not leading to 
Admitted (Sheet: TPCTAandEMSNA) 
Q18-21 Hospital outpatient clinics 99 NSRC2009-10 face to face outpatient 
appointments (weighted average, consultant and 
non-consultant-led, first attendance and follow-
ups) 
Q23 & 24 Visit to GP 32 UC2010 Section 2.8 (11.7 minute consultation)a 
Q25a GP practice nurse consultation 10 UC2010 Section 10.6 (Nurse GP Practice, per 
consultation) a 
Q25b School nurse time (per hour) 64  UC2010 (Community Nurse, per hour with patient, 
£16 per 15 minute appointment) a 
Q25c Counsellor (per hour)b 44 UC2010 Section 2.14  (Counselling services in 
primary medical care, per hour with patient or per 
contact hour) a 
Q25d Child Mental Health Service (per 
hour)b 
48 UC2010 (Mental Health Nurse, per hour with 
patient) a 
Q25e Child psychologist (per hour)b 81 UC2010 Section 9.5 (Clinical Psychologist, per 
hour with patient) a 
Q25f Social worker (per hour)b 53 UC2010 Section 11.3 (Social worker (children), 
per hour with client) a 
a Including direct care staff costs, but excluding qualification/training costs. 
b Appointments assumed to last an average of one hour with these practitioners, except for school nurses (15 minutes) 
c After deleting HRG codes and costs for inpatient stay reasons which are either (i) extremely unlikely to be applicable to children aged 
13-14 years, or (ii) which are specific codes for those aged 19 years or older. 
Abbreviations: NSRC = National Schedule of Reference Costs for PCTs and NHS Trusts combined  (20); UC2010 = Unit Costs of 
Health and Social Care, 2010 
 
 
